SPONTANEOUS APOPTOSIS OF TUMOR-SPECIFIC TETRAMER+ CD8+ T LYMPHOCYTES IN THE PERIPHERAL CIRCULATION OF PATIENTS WITH HEAD AND NECK CANCER

被引:14
作者
Albers, Andreas E. [1 ,2 ]
Schaefer, Carsten [1 ,3 ]
Visus, Carmen [1 ]
Gooding, William [1 ]
DeLeo, Albert B. [1 ,4 ]
Whiteside, Theresa L. [1 ,4 ]
机构
[1] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15213 USA
[2] Charite, Dept Otorhinolaryngol & Head & Neck Surg, D-13353 Berlin, Germany
[3] Univ HNO Klin Mannheim, Mannheim, Germany
[4] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15213 USA
来源
HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 2009年 / 31卷 / 06期
关键词
apoptosis; tetramers; effector T lymphocytes; tumor antigen-specific T cells; SQUAMOUS-CELL CARCINOMA; IMMUNE ESCAPE; EXPRESSION; RECEPTOR; DEATH; MICROENVIRONMENT; ABNORMALITIES; MICROVESICLES; MECHANISMS; DEFECTS;
D O I
10.1002/hed.21031
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Background. In cancer, tumor escape from the host immune system includes apoptosis of circulating CD3(+)CD8(+) effector T lymphocytes. Here, we compare sensitivity to apoptosis of virus- with tumor-specific circulating CD8(+) T cells in patients with head and neck cancer. Methods. Wild-type p53 peptice-specific (p53(264-272) and p53(149-157)) and viral peptide-specific (EBV BMLF259-267 and CMVpp65(495-503)) tetramers were used to measure the frequency of reactive T cells by flow cytometry. Annexin V (ANX) binding to circulating 7-amino-actinomycin D-negative but tetramer(+)CD8(+) T cells in PBMC obtained from 21 patients with head and neck cancer and 11 normal controls (NC) was evaluated. Results. In patients with head and neck cancer, a higher percentage of tetramer(+)CD8(+) than tetramer(-)CD8(+) T cells bound ANX (p < .023-005). Although most tumor-epitope(+)CD8(+) T cells bound ANX, lower percentages of virus-specific CD8(+) T cells were ANX(+) in the same patients. Conclusions. Preferential demise of circulating tumor-specific CD8(+) T cells and their paucity in head and neck cancer contribute to tumor escape. (c) 2009 Wiley Periodicals, Inc. Head Neck 31: 773-781, 2009
引用
收藏
页码:773 / 781
页数:9
相关论文
共 28 条
[1]  
ALBERS AE, 2005, CANCER IMMUNOL IMMUN, V62, P670
[2]   Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles [J].
Andreola, G ;
Rivoltini, L ;
Castelli, C ;
Huber, V ;
Perego, P ;
Deho, P ;
Squarcina, P ;
Accornero, P ;
Lozupone, F ;
Lugini, L ;
Stringaro, A ;
Molinari, A ;
Arancia, G ;
Gentile, M ;
Parmiani, G ;
Fais, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (10) :1303-1316
[3]   Down-regulation of the interferon signaling pathway in T lymphocytes from patients with metastatic melanoma [J].
Critchley-Thorne, Rebecca J. ;
Yan, Ning ;
Nacu, Serban ;
Weber, Jeffrey ;
Holmes, Susan P. ;
Lee, Peter P. .
PLOS MEDICINE, 2007, 4 (05) :897-911
[4]   FEATURES OF APOPTOTIC CELLS MEASURED BY FLOW-CYTOMETRY [J].
DARZYNKIEWICZ, Z ;
BRUNO, S ;
DELBINO, G ;
GORCZYCA, W ;
HOTZ, MA ;
LASSOTA, P ;
TRAGANOS, F .
CYTOMETRY, 1992, 13 (08) :795-808
[5]  
Dworacki G, 2001, CLIN CANCER RES, V7, p947S
[6]  
Gastman BR, 1999, CANCER RES, V59, P1422
[7]  
Hoffmann TK, 2000, CYTOMETRY, V41, P321, DOI 10.1002/1097-0320(20001201)41:4<321::AID-CYTO11>3.3.CO
[8]  
2-0
[9]  
Hoffmann TK, 2002, CLIN CANCER RES, V8, P2553
[10]  
Hoffmann TK, 2002, CANCER RES, V62, P3521